Red Blood Cell Enzymes and their Clinical Application

Advances in Clinical Chemistry

Volumn 33, Issue C, 1998, Pages 1-54

  Fujii, Hisaichi ^a   Miwa, Shiro ^a  

^a Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME;

ANEMIA; CHEMISTRY; DISORDERS OF CARBOHYDRATE METABOLISM; ENZYMOLOGY; ERYTHROCYTE; GENETICS; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; REVIEW;

ANEMIA; ANEMIA, HEMOLYTIC; CARBOHYDRATE METABOLISM, INBORN ERRORS; ENZYMES; ERYTHROCYTES; HEMATOLOGIC DISEASES; HUMANS;

EID: 0032250556     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(08)60205-X     Document Type: Article

References (303)

1. Ahluwalia A., Corcoran C.M., Vulliamy T.J., Ishwad C.S., Naidu J.M., Argusti A., Stevens D.J., Mason P.J., and Luzzatto L. G6PD Kalyan and G6PD Kerala: Two deficient variants in India caused by the same 317 Glu→Lys mutation. Hum. Mol. Genet. 1 (1992) 209-210
2. Allderdice P.W., Kaita H., Lewis M., McAlpine P.J., Wong P., Anderson J., and Giblett E.R. Segregation of marker loci in families with an inherited paracentric insertion of chromosome 9. Am. J. Hum. Genet. 39 (1986) 612-617
3. Allen S., and Muirhead H. Refined three-dimensional structure of cat-muscle (M1) pyruvate kinase at a resolution of 2.6 Å. Acta Crystallogr., Sect. D: Biol. Crystallogr. D52 (1996) 499-504
4. Arredondo-Vega F.X., Santisteban I., Kelly S., Schlossman C., Umetsu D., and Hershfield M.S. Correct splicing despite a G→A mutation at the invariant first nucleotide of a 5′ splice site: A possible basis for disparate clinical phenotypes in siblings with adenosine deaminase (ADA) deficiency. Am. J. Hum. Genet. 54 (1994) 820-830
5. Arya R., Lalloz M.R.A., Bellingham A.J., and Layton D.M. Molecular pathology of human triosephosphate isomerase. Blood 86 Suppl. 1 (1995) 585a
6. Arya R., Lalloz M.R.A., Nicolaides K.H., Bellingham A.J., and Layton D.M. Prenatal diagnosis of triosephosphate isomerase deficiency. Blood 87 (1996) 4507-4509
7. Banks R.D., Blake C.C.F., Evans P.R., Haser R., Rice D.W., Hardy G.W., Merett M., and Phillips A.W. Sequence, structure and activity of phosphoglycerate kinase: A possible hinge-bending enzyme. Nature 279 (1979) 773-777
8. Barichard F., Joulin V., Henry I., Garel M.-C., Valentin C., Rosa R., Cohen-Solal M., and Junien C. Chromosomal assignment of the human 2,3-bisphosphoglycerate mutase gene (BPGM) to region 7q34→7q22. Hum. Genet. 77 (1987) 283-285
9. Baronciani L., and Beutler E. Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 4324-4327
10. Baronciani L., Tricta F., and Beutler E. G6PD "Campinas": A deficient enzyme with a mutation at the far 3′ end of the gene. Hum. Mutat. 2 (1993) 77-78
11. Baronciani L., and Beutler E. Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia. J. Clin. Invest. 95 (1995) 1702-1709
12. Baronciani L., Magalhães I.Q., Mahoney Jr. D.H., Westwood B., Adekile A.D., Lappin T.R.J., and Beutler E. Study of the molecular defects in pyruvate kinase deficient patients affected by nonspherocytic hemolytic anemia. Blood Cells Mol. Dis. 21 (1995) 49-55
13. Baronciani L., Bianchi P., and Zanella A. Hematologically important mutations: Red cell pyruvate kinase. Blood Cells Mol. Dis. 22 (1996) 85-89
14. st update). Blood Cells Mol. Dis. 22 (1996) 259-264
15. Baronciani L., Zanella A., Bianchi P., Zappa M., Alfinito F., Iolascon A., Tannoia N., Beutler E., and Sirchia G. Study of the molecular defects in glucose phosphate isomerase-deficient patients affected by chronic hemolytic anemia. Blood 88 (1996) 2306-2310
16. Baughan M.A., Valentine W.N., Paglia D.E., Ways P.O., Simon E.R., and DeMarsh Q.B. Hereditary hemolytic anemia associated with glucosephosphate isomerase (GPI) deficiency-A new enzyme defect of human erythrocytes. Blood 32 (1969) 236-249
17. Betke K., Beutler E., Brewer G.J., Kirkman H.N., Luzzatto L., Motulsky A.G., Ramot B., and Siniscalco M. Standardization of procedures for the study of glucose-6-phosphate dehydrogenase. Report of a WHO scientific group. WHO Tech. Rep. Ser. 366 (1967) 1-53
18. Beutler E., Dern R.J., Flanagan C.L., and Alving A.S. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. J. Lab. Clin. Med. 45 (1955) 286-295
19. Beutler E., Scott S., Bishop A., Margolis N., Matsumoto F., and Kuhl W. Red cell aldolase deficiency and hemolytic anemia: A new syndrome. Trans. Assoc. Am. Physicians 76 (1973) 154-166
20. Beutler E., Blume K.G., Kaplan J.C., Löhr G.W., Ramot B., and Valentine W.N. International Committee for Standardization in Haematology: Recommended methods for red cell enzyme analysis. Br. J. Haematol. 35 (1977) 331-340
21. Beutler E., Carson D., Dannawi H., Forman L., Kuhl W., West C., and Westwood B. Metabolic compensation for profound erythrocyte adenylate kinase deficiency: A hereditary enzyme defect without hemolytic anemia. J. Clin. Invest. 72 (1983) 648-655
22. Beutler E. "Red Cell Metabolism: A Manual of Biochemical Methods,". 3rd ed. (1984), Grune & Stratton, Orlando
23. Beutler E., Kuhl W., Vives-Corrons J.-L., and Prchal J.T. Molecular heterogeneity of glucoses-6-phosphate dehydrogenase A-. Blood 74 (1989) 2550-2555
24. Beutler E., Moroose R., Lawrence K., Kramer L., Gelbart T., and Forman L. Gamma-glutamylcysteine synthetase deficiency and hemolytic anemia. Blood 75 (1990) 271-273
25. Beutler E., and Kuhl W. The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia. Am. J. Hum. Genet. 47 (1990) 1008-1012
26. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. New Engl. J. Med. 324 (1991) 169-174
27. Beutler E., Kuhl W., Gelbart T., and Forman L. DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants. J. Biol. Chem. 266 (1991) 4145-4150
28. Beutler E., Kuhl W., Ramirez E., and Lisker R. Some Mexican glucose-6-phosphate dehydrogenase (G-6-PD) variants revisited. Hum. Genet. 86 (1991) 371-374
29. Beutler E., Kuhl W., Saenz R.G.F., and Rodrigues R.W. Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica. Hum. Genet. 87 (1991) 462-464
30. Beutler E., Westwood B., and Kuhl W. Definition of the mutation of G6PD Wayne. G6PD Viangchan, G6PD Jammu, and G6PD 'LeJeune'. Acta Haematol. 86 (1991) 179-182
31. Beutler E., Westwood B., Kuhl W., and Hsia Y.E. Glucose-6-phosphate dehydrogenase variants in Hawaii. Hum. Hered. 42 (1992) 327-329
32. Beutler E., Westwood B., Prchal J., Vaca G., Bartsocas C.S., and Baronciani L. New glucose-6-phosphate dehydrogenase mutations from various ethnic groups. Blood 80 (1992) 255-256
33. Beutler E., Westwood B., Melemed A., Borgo P.D., and Margolis D. Three new exon 10 glucose-6-phosphate dehydrogenase mutations. Blood Cells Mol. Dis. 21 (1995) 64-72
34. Beutler E., and Baronciani L. Mutations in pyruvate kinase. Hum. Mutat. 7 (1996) 1-6
35. Beutler E., Vuliamy T., and Luzzatto L. Hematologically important mutations: Glucose-6-phosphate dehydrogenase. Blood Cells Mol. Dis. 22 (1996) 49-56
36. Bianchi P., Terragna C., Zappa M., Alfinito F., and Zanella A. Molecular characterization of L-PK gene in pyruvate kinase (PK) deficient Italian patients. Blood 84 Suppl. 1 (1994) 14a
37. Bianchi M., and Magnani M. Hexokinase mutations that produce nonspherocytic hemolytic anemia. Blood Cells Mol. Dis. 21 (1995) 2-8
38. Bianchi P., Zanella A., Zappoa M., Vercellati C., Terragna C., Baronciani L., and Sirchia G. A new point mutation G/A 1168 (Asp390-Asn) in an Italian patient with erythrocyte pyrivate kinase deficiency. Blood 86 Suppl. 1 (1995) 133a
39. Boivin P., Galand C., Hakim J., Simony J., and Seligman M. Une nouvelle erythroenzy-mopathies: Anemie hemolytique congenitale non spherocytaire et deficit hereditaire en adenylate-kinase erythrocytaire. Presse Med. 79 (1971) 215-218
40. Brady H.J.M., Sowden J.C., Edwards M., Lowe N., and Butterworth P.H.W. Multiple GF-1 binding sites flank the erythroid specific transcription unit of the human carbonic anhydrase I gene. FEBS Lett. 257 (1989) 451-456
41. Brown J.R., Daar I.O., Krug J.R., and Maquart L.E. Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family. Mol. Cell. Biol. 5 (1985) 1694-1707
42. Calabro V., Mason P.J., Filosa S., Civitelli D., Cittadella R., Tagarelli A., Martini G., Brancati C., and Luzzatto L. Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis. Am. J. Hum. Genet. 52 (1993) 527-536
43. Cappellini M.D., Martinez di Montemuros F., Dotti C., Tavazzi D., De Bellis G., Debernardi S., and Fiorelli G. Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) Mediterranean type in Italy. Blood 84 Suppl. 1 (1994) 114a
44. Carson P.E., Flanagan C.L., Ickes C.E., and Alving A.S. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 124 (1956) 484-485
45. Chang J.-G., Chiou S.-S., Perng L.-I., Chen T.-C., Liu T.-C., Lee L.-S., Chen P.-H., and Tang T.K. Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: Five mutations account for most G6PD deficiency cases in Taiwan. Blood 80 (1992) 1079-1082
46. Chang M.-L., Artymiuk P.J., Wu X., Hollán S., Lammi A., and Maquat L.E. Human triosephosphate isomerase deficiency resulting from mutation of Phe-240. Am. J. Hum. Genet. 52 (1993) 1260-1269
47. Chao L., Du C.-S., Louis E., Zuo L., Chen E., Lubin B., and Chiu D.T.Y. A to G substitution identified in exon 2 of the G6PD gene among G6PD deficient Chinese. Nucleic Acids Res. 19 (1991) 6056
48. Chaput M., Claes V., Portetelle D., Cludts I., Cravador A., Burny A., Gras H., and Tartar A. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature 332 (1988) 454-455
49. Chen E.H., Tartaglia A.P., and Mitchell B.S. Hereditary overproduction of adenosine deaminase in erythrocytes: Evidence for a cis-acting mutation. Am. J. Hum. Genet. 53 (1993) 889-893
50. Cheng J., and Maquat L.E. Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA. Mol. Cell. Biol. 13 (1993) 1892-1902
51. Chiu D.T., Zuo L., Chen E., Chao L., Louie E., Lubin B., Liu T.Z., and Du C.-S. Two commonly occurring nucleotide base substitutions in Chinese G6PD variants. Biochem. Biophys. Res. Commun. 180 (1991) 988-993
52. Chung F.-Z., Tsujibo H., Bhattacharyya U., Sharief F.S., and Li S.S.-L. Genomic organization of human lactate dehydrogenase-A gene. Biochem. J. 231 (1985) 537-541
53. Cohen-Solal M., Valentin C., Plassa F., Guillemin G., Danze F., Jaisson F., and Rosa R. Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Créteil and PGK Amiens. Blood 84 (1994) 898-903
54. Corcoran C.M., Calabro V., Tamagnini G., Town M., Haidar B., Vulliamy T.J., Mason P.J., and Luzzatto L. Molecular heterogeneity underlying the G6PD Mediterranean phenotype. Hum. Genet. 88 (1992) 688-690
55. Daar I.O., Artymiuk P.J., Phillips D.C., and Maquat L.E. Human triosephosphate isomerase deficiency. A single amino acid substitution results in a thermolabile enzyme. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 7903-7907
56. Daar I.O., and Maquat L.E. Premature translation termination mediates triosephosphate isomerase mRNA degradation. Mol. Cell. Biol. 8 (1988) 802-813
57. Daimon M., Yamatani K., Igarashi M., Fukase N., Morita Y., Ogawa A., Tominaga M., and Sasaki H. Acute intermittent porphyria caused by a single base insertion of C in exon 15 of the porphobilinogen deaminase gene that results in a frame shift and premature stopping of translation. Hum. Genet. 93 (1994) 533-537
58. De Vita G., Alcalay M., Sampietro M., Cappelini D., Fiorelli G., and Toniolo D. Two point mutations are responsible for G6PD polymorphism in Sardinia. Am. J. Hum. Genet. 44 (1989) 233-240
59. Dern R.J., Weinstein I.M., Le Roy G.V., Talmage D.W., and Alving A.S. The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals. J. Lab. Clin. Med. 43 (1954) 303-309
60. Elas L.J., Langley S., Steele E., Evinger J., Fridovich-Keil J.L., Brown A., Singh R., Fernhoff P., Hjelm L.N., and Dermbure P.P. Galactosemia: A strategy to identify new biochemical phenotypes and molecular genotypes. Am. J. Hum. Genet. 56 (1995) 630-639
61. Endo F., Tanoue A., Nakai H., Hata A., Indo Y., Titani K., and Matsuda I. Primary structure and gene localization of human prolidase. J. Biol. Chem. 264 (1989) 4476-4481
62. Eto K., Sakura H., Yasuda K., Hayakawa T., Kawasaki E., Moriuchi R., Nakataki S., Yazaki Y., and Kadowaki T. Cloning of a complete protein-coding sequence of human platelet-type phosphofructokinase isozyme from pancreatic islet. Biochem. Biophys. Res. Commun. 198 (1994) 990-998
63. Faik P., Walker J.I.H., Redmill A.A.M., and Morgan M.J. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3′ sequences. Nature 332 (1988) 455-457
64. G6P and marked in vivo instability. Br. J. Haematol. 80 (1992) 111-116
65. Filosa S., Calabró V., Lania G., Vulliamy T.J., Brancati C., Tagarelli A., Luzzatto L., and Martini G. G6PD haplotypes spanning Xq28 from F8C to red/green color vision. Genomics 17 (1993) 6-14
66. Filosa S., Cai W., Galanello R., Cao A., De Mattia D., Schettini F., and Martini G. A novel single-base mutation in the glucose 6-phosphate dehydrogenase gene is associated with chronic non-spherocytic haemolytic anaemia. Hum. Genet. 94 (1994) 560-562
67. Fujii H., Krietsch W.K.G., and Yoshida A. A single amino acid substitution (Asp→Asn) in a phosphoglycerate kinase variant (PGK München) associated with enzyme deficiency. J. Biol. Chem. 255 (1980) 6421-6423
68. Fujii H., Miwa S., and Suzuki K. Purification and properties of adenosine deaminase in normal and hereditary hemolytic anemia with increased red cell activity. Hemoglobin 4 (1980) 693-705
69. Fujii H., and Yoshida A. Molecular abnormality of phosphoglycerate kinase-Uppsala associated with chronic nonspherocytic hemolytic anemia. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 5461-5465
70. Fujii H., Chen S.-H., Akatsuka J., Miwa S., and Yoshida A. Use of cultured lymphoblastoid cells for the study of abnormal enzymes: Molecular abnormality of a phosphoglycerate kinase variant associated with hemolytic anemia. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 2587-2590
71. Fujii H., Miwa S., Tani K., Fujinami N., and Asano H. Overproduction of structurally normal enzyme in man: Hereditary hemolytic anemia with increased red cell adenosine deaminase activity. Br. J. Haematol. 51 (1982) 427-430
72. Fujii H., and Miwa S. Red cell enzymes. In: Schmidt R.M., and Fairbanks V.F. (Eds). "CRC Handbook Series in Clinical Laboratory Science," Section I: Hematology IV (1986), CRC Press, Boca Raton 307-352
73. Fujii H., and Miwa S. Recent progress in the molecular genetic analysis of erythroenzymopathy. Am. J. Hematol. 34 (1990) 301-310
74. Fujii H., Kanno H., Hirono A., Shiomura T., and Miwa S. A single amino acid substitution (157 Gly→Val) in a phosphoglycerate kinase variant (PGK Shizuoka) associated with chronic hemolysis and myoglobinuria. Blood 79 (1992) 1582-1585
75. Fujii H., Kanno H., Hirono A., and Miwa S. Hematologically important mutations: Molecular abnormalities of glucose phosphate isomerase deficiency. Blood Cells Mol. Dis. 22 (1996) 96-97
76. Fujii H., Kanno H., and Miwa S. Expression and enzymatic characterization of the glucose phosphate isomerase variants with diverse single amino acid substitutions. Blood 88 Suppl. 1 (1996) 306a
77. Furuta H., Nishi S., Le Beau M.M., Fernald A.A., Yano H., and Bell G.I. Sequence of human hexokinase III cDNA and assignment of the human hexokinase III gene (HK3) to chromosome band 5q35.2 by fluorescence in situ hybridization. Genomics 36 (1996) 206-209
78. Gali R.R., and Board P.G. Sequence and expression of a cDNA for human glutathione synthetase. Biochem. J. 310 (1995) 353-358
79. Ganczakowski M., Town M., Bowden D.K., Vulliamy T.J., Kaneko A., Clegg J.B., Weatherall D.J., and Luzzatto L. Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am. J. Hum. Genet. 56 (1995) 294-301
80. Gartler S.M., Reley D.F., Levo R.V., Cheung M.-C., Eddy R.L., and Shows T.B. Mapping of human autosomal phosphoglycerate kinase sequence to chromosome 19. Somat. Cell Mol. Genet. 12 (1986) 395-401
81. Giblett E.R., Ammann A.J., Wara D.W., Sandman R., and Diamond L.K. Nucleoside phosphorylase deficiency in a child with severely defective T cell immunity and normal B cell immunity. Lancet 1 (1975) 1010-1013
82. Gipp J.J., Chang C., and Mulcahy R.T. Cloning and nucleotide sequence of a full length cDNA for human liver γ-glutamylcysteine synthetase. Biochem. Biophys. Res. Commun. 185 (1992) 29-35
83. Gipp J.J., Bailey H.H., and Mulcahy R.T. Cloning and sequencing of the cDNA for the light subunit of human liver γ-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in normal tissues. Biochem. Biophys. Res. Commun. 206 (1995) 584-589
84. Gurney M.E., Heinrich S.P., Lee M.R., and Yin H.-S. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science 234 (1986) 566-581
85. Hamaguchi T., Nakajima H., Noguchi T., Ono A., Kono N., Tarui S., Kuwajima M., and Matsuzawa Y. A new variant of muscle phosphofructokinase deficiency in a Japanese case with abnormal splicing. Biochem. Biophys. Res. Commun. 202 (1994) 444-449
86. Hamaguchi T., Nakajima H., Noguchi T., Nakagawa C., Kuwajima M., Kono N., Tarui S., and Matsuzawa Y. Novel missense mutation (W686C) of the phosphofructokinase-M gene in a Japanese patient with a mild form of glycogenosis VII. Hum. Mutat. 8 (1996) 273-275
87. Hershfield M.S., Chaffee S., and Sorensen R.U. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: Overview and case reports of three patients, including two now receiving gene therapy. Pediatr. Res. 33 (1993) S42-S48 (Suppl.)
88. Hershfield M.S., and Mitchell B.S. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). "Metabolic and Molecular Bases of Inherited Disease,". 7th ed. (1995), McGraw-Hill, New York 1725-1768
89. Hidaka Y., Tarle S.A., Fujimori S., Kamatani N., Kelley W.N., and Palella T.D. Human adenine phosphoribosyltransferase deficiency: Demonstration of a single mutant allele common to the Japanese. J. Clin. Invest. 81 (1988) 945-950
90. Hirono A., Fujii H., Natori H., Kurokawa I., and Miwa S. Chromatographic analysis of human erythrocyte pyrimidine 5′-nucleotidase from five patients with primidine 5′-nucleotidase deficiency. Br. J. Haematol. 65 (1987) 35-41
91. Hirono A., and Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-). Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 3951-3954
92. + of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 10015-10017
93. Hirono A., Fujii H., Hirono K., Kanno H., and Miwa S. Molecular abnormality of a Japanese glucose-6-phosphate dehydrogenase variant (G6PD Tokyo) associated with hereditary nonspherocytic hemolytic anemia. Hum. Genet. 88 (1991) 387-388
94. Hirono A., Fujii H., and Miwa S. Molecular abnormality of G6PD Konan and G6PD Ube, the most common glucose-6-phosphate dehydrogenase variants in Japan. Hum. Genet. 91 (1993) 507-508
95. Hirono A., Fujii H., Shima M., and Miwa S. G6PD Nara: A new class 1 glucose-6-phosphate dehydrogenase variant with an eight amino acid deletion. Blood 82 (1993) 3250-3252
96. Hirono A., Nakayama S., Fujii H., and Miwa S. Molecular abnormality of a unique Japanese glucose-6-phosphate dehydrogenase variant (G6PD Kobe) with an extremely increased affinity for galactose 6-phosphate. Am. J. Hematol. 45 (1994) 185-186
97. Hirono A., Miwa S., Fujii H., Ishida F., Yamada K., and Kubota K. Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by non-radioisotopic single-strand conformation polymorphism (SSCP) analysis. Blood 83 (1994) 3363-3368
98. Hirono A., Ishii A., Kere N., Fujii H., Hirono K., and Miwa S. Molecular analysis of glucose-6-phosphate dehydrogenase variants in the Solomon Islands. Am. J. Hum. Genet. 56 (1995) 1243-1245
99. Hirono A., Fujii H., and Miwa S. Identification of two novel deletion mutations in glucose-6-phosphate dehydrogenase gene causing hemolytic anemia. Blood 85 (1995) 1118-1121
100. Hirono A., Sasaya-Hamada F., Kanno H., Fujii H., Yoshida T., and Miwa S. A novel human catalase mutation (358 T→del) causing Japanese-type acatalasemia. Blood Cells Mol. Dis. 21 (1995) 232-234
101. Hirono A., Iyori H., Sekine I., Ueyama J., Chiba H., Kanno H., Fujii H., and Miwa S. Three cases of hereditary nonspherocytic hemolytic anemia associated with red blood cell glutathione deficiency. Blood 87 (1996) 2071-2074
102. Hirono, A., et al., Unpublished, 1996 G6PD
103. Hirschhorn R. Adenosine deaminase deficiency. Immunodefic. Rev. 2 (1990) 175-198
104. Hirschhorn R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr. Res. 33 (1993) S35-S41 (Suppl.)
105. Howard T.D., Akots G., and Bowden D.W. Physical and genetic mapping of the muscle phosphofructokinase gene (PFKM): Reassignment to human chromosome 12q. Genomics 34 (1996) 122-127
106. Huang I.-Y., Welch C.D., and Yoshida A. Complete amino acid sequence of human phosphoglycerate kinase: Cyanogen bromide peptides and complete amino acid sequence. J. Biol. Chem. 255 (1980) 6412-6420
107. Ishida K., Morino T., Takagi K., and Sukenaga Y. Nucleotide sequence of a human gene for glutathione peroxidase. Nucleic Acids Res. 15 (1987) 10051
108. Jhanwar S.C., Berkvens T.M., Breukel C., van Ormondt H., van der Eb A.J., and Meera Khan P. Localization of human adenosine deaminase (ADA) gene sequences to the q12→q13.11 region of chromosome 20 by in situ hybridization. Cytogenet. Cell. Genet. 50 (1989) 168-171
109. Johns R.J. Familial reduction in red-cell cholinesterase. New Engl. J. Med. 267 (1962) 1344-1348
110. Jolly D.J., Okayama H., Berg P., Esty A.C., Filpula D., Bohlen P., Johnson G.G., Shively J.E., Hunkapillar T., and Friedmann T. Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl-transferase. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 477-481
111. Joulin V., Peduzzi J., Remeo P.-H., Rosa R., Valentin C., Dubart A., Lapeyre B., Blouquit Y., Garel M.-C., Goossens M., Rosa J., and Cohen-Solal M. Molecular cloning and sequence of the human erythrocyte 2,3-bisphosphoglycerate mutase cDNA: Revised amino acid sequence. EMBO J. 5 (1986) 2275-2283
112. Joulin V., Garel M.-C., Le Boulch P., Valentin C., Rosa R., Rosa J., and Cohen-Solal M. Isolation and characterization of the human 2,3-bisphosphoglycerate mutase gene. J. Biol. Chem. 263 (1988) 15785-15790
113. Junien C., Despoisse S., Turleau C., de Grouchy J., Bücher J., and Fundele T. Assignment of phosphoglycerate mutase (PGAMA) to human chromosome 10. Regional mapping of GOT 1, and PGAMA to subbands 10q26.1 (or q25.3). Ann. Genet. 25 (1982) 25-27
114. Kaeda J.S., Chhotray G.P., Ranjit M.R., Bautista J.M., Reddy P.H., Stevens J.M., Naidu J.M., Britt R.P., Vulliamy T.J., Luzzatto L., and Mason P.J. A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala→Gly), is the major polymorphic variant in tribal populations in India. Am. J. Hum. Genet. 57 (1995) 1335-1341
115. Kamatani N., Hakoda M., Otsuka S., Yoshikawa H., and Kashiwazaki S. Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients. J. Clin. Invest. 90 (1992) 130-135
116. Kanno H., Tani K., Fujii H., Iguchi-Ariga S.M.M., Ariga H., Kozaki T., and Miwa S. Adenosine deaminase (ADA) overproduction associated with congenital hemolytic anemia: Case report and molecular analysis. J. Exp. Med. 58 (1988) 1-8
117. 384→Met) affecting enzymatic stability in a pyruvate kinase variant (PK Tokyo) associated with hereditary hemolytic anemia. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8218-8221
118. Kanno H., Fujii H., Hirono A., Omine M., and Miwa S. Identical point mutations of the R-type pyruvate kinase (PK) cDNA found in unrelated PK variants associated with hereditary hemolytic anemia. Blood 79 (1992) 1347-1350
119. Kanno H., Fujii H., and Miwa S. Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells. Biochem. Biophys. Res. Commun. 188 (1992) 516-523
120. Kanno H., Fujii H., and Miwa S. Low substrate affinity of pyruvate kinase variant (PK Sapporo) due to a single amino acid substitution (426Arg→Gln) associated with hereditary hemolytic anemia. Blood 81 (1993) 2439-2441
121. Kanno H., Fujii H., Tsujino G., and Miwa S. Molecular basis of impaired pyruvate kinase isozyme conversion in erythroid cells: A single amino acid substitution near the active site and decreased mRNA content of the R-type PK. Biochem. Biophys. Res. Commun. 192 (1993) 46-52
122. Kanno H., Wei D.C.C., Miwa S., Chan L.C., and Fujii H. Identification of a 5′-splice site mutation and a missense mutation in homozygous pyruvate kinase deficiency cases found in Hong Kong. Blood 82 Suppl. 1 (1993) 97a
123. Kanno H., Ballas S.K., Miwa S., Fujii H., and Bowman H.S. Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish. Blood 83 (1994) 2311-2316
124. Kanno H., Fujii H., and Miwa S. Molecular heterogeneity of pyruvate kinase deficiency identified by single strand conformational polymorphism (SSCP) analysis. Blood 84 Suppl. 1 (1994) 13a
125. Kanno H., Wei D.C.C., Chan L.C., Mizoguchi H., Ando M., Nakahata T., Narisawa K., Fujii H., and Miwa S. Hereditary hemolytic anemia caused by diverse point mutations of pyruvate kinase gene found in Japan and Hong Kong. Blood 84 (1994) 3505-3509
126. Kanno H., Morimoto M., Fujii H., Kasugai T., Noguchi T., Kitamura Y., and Miwa S. Primary structure of murine red cell type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain. Blood 86 (1995) 3205-3210
127. Kanno H., Fujii H., Hirono A., Ishida Y., Ohga S., Fukumoto Y., Matsuzawa K., and Miwa S. Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia. Blood 88 (1996) 2321-2325
128. Kanno T., Sudo K., Takeuchi I., Kanda S., Honda N., Nishimura Y., and Oyama K. Hereditary deficiency of lactate dehydrogenase M-subunit. Clin. Chim. Acta 108 (1980) 267-276
129. Kanno T., and Maekawa M. Lactate dehydrogenase M-subunit deficiencies: Clinical features, metabolic background, and genetic heterogeneities. Muscle Nerve Suppl. 3 (1995) S54-S60
130. Karplus P.A., and Schulz G.E. Refined structure of glutathione reductase at 1.54 A resolution. J. Mol. Biol. 195 (1987) 701-729
131. Kelley W.N., Rosenbloom F.M., Henderson J.F., and Seegmiller J.E. Adenine phosphoribosyltransferase deficiency: Apreviously undescribed genetic defect in man. J. Clin. Invest. 47 (1968) 2281-2289
132. Kishi H., Mukai T., Hirono A., Fujii H., Miwa S., and Hori K. Human aldolase A deficiency associated with a hemolytic anemia: Thermolabile aldolase due to a single base mutation. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 8623-8627
133. Kishimoto Y., Murakami Y., Hayashi K., Takahara S., Sugimura T., and Sekiya T. Detection of a common mutation of the catalase gene in Japanese acatalasemic patients. Hum. Genet. 88 (1992) 487-490
134. Kitamura M., Iijima N., Hashimoto F., and Hiratsuka A. Hereditary deficiency of subunit H of lactate dehydrogenase. Clin. Chim. Acta 34 (1971) 419-423
135. Kogure K., Yamamoto K., Majima E., Shinohara Y., Yamashita K., and Terada H. Alteration of enzyme function of the type II hexokinase C-terminal half on replacements of restricted regions by corresponding regions of glucokinase. J. Biol. Chem. 271 (1996) 15230-15236
136. Konrad P.N., Richards Fii., Valentine W.N., and Paglia D.E. Gamma-glutamylcysteine synthetase deficiency. New Engl. J. Med. 286 (1972) 557-561
137. Kraus A.P., Langston Jr. M.F., and Lynch B.L. Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia. Biochem. Biophys. Res. Commun. 30 (1968) 173-177
138. Kreuder J., Borkhardt A., Repp R., Pekrun A., Göttsche B., Gottschalk U., Reichmann H., Schachenmayr W., Schiegel K., and Lampert F. Inherited metabolic myopathy and hemolysis due to a mutation in aldolase A. New Engl. J. Med. 334 (1996) 1100-1104
139. Lachant N.A., Zerez C.R., Barredo J., Lee D.W., Savely S.M., and Tanaka K.R. Hereditary erythrocyte adenylate kinase deficiency: A defect of multiple phosphotransferases?. Blood 77 (1991) 2774-2784
140. Lakomek M., Huppke P., Neubauer B., Pekrun A., Winkler H., and Schröter W. Mutations in the R-type pyruvate kinase gene and altered enzyme kinetic properties in patients with hemolytic anemia due to pyruvate kinase deficiency. Ann. Hematol. 68 (1994) 253-260
141. Layton D.M., Kanno H., Arya R., McGonigle D., Wild B., Colvin B.T., Fujii H., Miwa S., and Bellingham A.J. Molecular basis of severe pyruvate kinase deficiency. Br. J. Haematol. 93 Suppl. 1 (1996) 84a
142. Lee Y., Kim J.W., Lee I.A., Kang H.B., Choe Y.-K., Lee H.G., Lim J.-S., Kim H.J., Park C., and Choe I.S. Cloning and characterization of cDNA for human adenylate kinase 2A. Biochem. Mol. Biol. Int. 39 (1996) 833-842
143. Lehto M., Xiang K., Stoffel M., Espinosa III R., Groop L.C., Le Beau M.M., and Bell G.I. Human hexokinase II: Localization of the polymorphic gene to chromosome 2. Diabetologia 36 (1993) 1299-1302
144. Lehto M., Huang X., Davis E.M., Le Beau M.M., Laurila K.F., Eriksson K.F., Bell G.I., and Groop L. Human hexokinase II gene: Exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity. Diabetologia 38 (1995) 1466-1474
145. Lemarchandel V., Joulin V., Valentin C., Rosa R., Galacteros F., Rosa J., and Cohen-Solal M. Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency. Blood 80 (1992) 2643-2649
146. Lenzner C., Nürnberg P., Thiele B.-J., Reis A., Brabec V., Sakalova A., and Jacobasch G. Mutations in the pyruvate kinase L gene in patients with hemolytic anemia. Blood 83 (1994) 2817-2822
147. Levanon D., Danciger E., Dafni N., Bernstein Y., Elson A., Moens W., Brandeis M., and Groner Y. The primary structure of human liver type phosphofructokinase and its comparison with other type PFK. DNA 8 (1989) 733-743
148. Löhr G.W., and Waller H.D. Eine neue enzymopenische hamolytische Anamie mit Glutathionreduktase-Mangel. Med. Klin. 57 (1962) 1521-1525
149. Loos H., Roos D., Weening R., and Houwerzijl J. Familial deficiency of glutathione reductase in human blood cells. Blood 48 (1976) 53-62 GR4
150. MacDonald D., Town M., Mason P., Vulliamy T., Luzzatto L., and Goff D.K. Deficiency in red blood cells. Nature 350 (1991) 115
151. Maeda M., and Yoshida A. Molecular defect of a phosphoglycerate kinase variant (PGK-Matsue) associated with hemolytic anemia: Leu→Pro substitution caused by T/A→C/G transition in exon 3. Blood 77 (1991) 1348-1352
152. Maeda M., Bawle E.V., Kulkarni R., Beutler E., and Yoshida A. Molecular abnormality of a phosphoglycerate kinase variant generated by spontaneous mutation. Blood 79 (1992) 2759-2762
153. Maeda M., Constantoulakis P., Chen C.-S., Stamatoyannopoulos G., and Yoshida A. Molecular abnormalities of a human glucose-6-phosphate dehydrogenase variant associated with undetectable enzyme activity and immunologically cross-reacting material. Am. J. Hum. Genet. 51 (1992) 386-395
154. Maekawa M., Sudo K., Kanno T., and Li S.S.-L. Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency. Biochem. Biophys. Res. Commun. 168 (1990) 677-682
155. Maekawa M., Sudo K., Kitajima M., Matsuura Y., Li S.S.-L., and Kanno T. Detection and characterization of new genetic mutations in individuals heterozygous for lactate dehydrogenase-B (H) deficiency using DNA conformation polymorphism analysis and silver staining. Hum. Genet. 91 (1993) 163-168
156. Magnani M., and Dallapiccola B. Regional mapping of the locus for hexokinase-1 (HK1). Hum. Genet. 62 (1982) 181
157. 5 reductase gene of a patient with generalized type, hereditary methemoglobinemia. Blood 88 (1996) 3208-3215
158. Mansouri A., and Lurie A.A. Methemoglobinemia. Am. J. Hematol. 42 (1993) 7-12
159. Maquat L.E., Chilcote R., and Ryan P.M. Human triosephosphate isomerase cDNA and protein structure: Studies of triosephosphate isomerase in man. J. Biol. Chem. 260 (1985) 3748-3753
160. Marie P., Gautron S., Hakim V., Gregori C., Mennecier F., and Kahn A. Characterization of three optional promoters in the 5′ region of the human aldolase A gene. J. Mol. Biol. 197 (1987) 425-438
161. Martini G., Toniolo D., Vulliamy T., Luzzatto L., Dono R., Viglitto G., Paonessa G., D'Urso M., and Persico M.G. Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J. 5 (1986) 1849-1855
162. Mason P.J., Sonati M.F., MacDonald D., Lanza C., Busutil D., Town M., Corcoran C.M., Kaeda J.S., Stevens D.J., Al-Ismail S., Altay C., Hatton C., Lewis D.S., McMullin M.F., Meloni T., Paul B., Pippard M., Prentice A.G., Vulliamy T.J., and Luzzatto L. New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia. Blood 85 (1995) 1377-1380
163. Matsuura S., Igarashi M., Tanizawa Y., Yamada M., Kishi F., Kajii T., Fujii H., Miwa S., Sakurai M., and Nakazawa A. Human adenylate kinase deficiency associated with hemolytic anemia. A single base substitution affecting solubility and catalytic activity of cytosolic adenylate kinase. J. Biol. Chem. 264 (1989) 10148-10155
164. Mattevi A., Bolognesi M., and Valentini G. The allosteric regulation of pyruvate kinase. FEBS Lett. 389 (1996) 15-19
165. McCarrey J.R., and Thomas K. Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. Nature 326 (1987) 501-505
166. McMorris F.A., Chen T.R., Ricciuti F., Tischfield J., Creagan R., and Ruddle F.H. Chromosome assignments in man of the genes for two hexosephosphate isomerases. Science 179 (1973) 1129-1131
167. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 263 (1988) 17205-17208
168. Michelson A.M., Markham A.F., and Orkin S.H. Isolation and DNA sequence of a full-length cDNA clone for human X-chromosome-encoded phosphoglycerate kinase. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 472-476
169. Michelson A.M., Blake C.C., Evans S.T., and Orkin S.H. Structure of the human phosphoglycerate kinase gene and the intron-mediated evolution and dispersal of the nucleotide-binding domain. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 6965-6969
170. Minakami S., Suzuki C., Saito T., and Yoshikawa H. Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes. J. Biochem. 58 (1965) 543-550
171. Miwa S., Fujii H., Matsumoto M., Nakatsuji T., Oda S., Asano H., Asano S., and Miura Y. A case of red-cell adenosine deaminase overproduction associated with hereditary hemolytic anemia found in Japan. Am. J. Hematol. 5 (1978) 107-115
172. Miwa S., Boivin P., Blume K.G., Arnold H., Black J.A., Kahn A., Staal G.E.J., Nakashima K., Tanaka K.R., Paglia D.E., Valentine W.N., Yoshida A., and Beutler E. International Committee for Standardization in Haematology: Recommended methods for the characterization of red cell pyruvate kinase variants. Br. J. Haematol. 43 (1979) 275-286
173. Miwa S., Fujii H., Tani K., Takahashi K., Takegawa S., Fujinami N., Sakurai M., Kubo M., Tanimoto Y., Kato T., and Matsumoto N. Two cases of red cell aldolase deficiency associated with hereditary hemolytic anemia in a Japanese family. Am. J. Hematol. 11 (1981) 425-437
174. Miwa S., Fujii H., Tani K., Takahashi K., Takizawa T., and Igarashi T. Red cell adenylate kinase deficiency associated with hereditary nonspherocytic hemolytic anemia: Clinical and biochemical studies. Am. J. Hematol. 14 (1983) 325-333
175. Miwa S., Luzzatto L., Rosa R., Paglia D.E., Schröter W., De Flora A., Fujii H., Board P.G., and Beutler E. International Committee for Standardization in Haematology: Recommended methods for an additional red cell enzyme (pyrimidine 5′-nucleotidase) assay and the determination of red cell adenosine 5′-triphosphate, 2,3-diphosphoglycerate and reduced glutathione. Clin. Lab. Haematol. 11 (1989) 131-138
176. Miwa S., Kanno H., and Fujii H. Concise review: Pyruvate kinase deficiency: Historical perspective and recent progress of molecular genetics. Am. J. Hematol. 42 (1993) 31-35
177. Miwa S., and Fujii H. Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: Tabulation of mutant enzymes. Am. J. Hematol. 51 (1996) 122-132
178. Morimoto M., Kanno H., Asai H., Tsujimura T., Fujii H., Moriyama Y., Kasugai T., Hirono A., Ohba Y., Miwa S., and Kitamura Y. Pyruvate kinase deficiency of mice associated with nonspherocytic hemolytic anemia and cure of the anemia by marrow transplantation without irradiation. Blood 86 (1995) 4323-4330
179. Morrison N., Simpson C., Fothergill-Gilmore L., Boyd E., and Connor J.M. Regional chromosomal assignment of the human platelet phosphofructokinase gene to 10p 15. Hum. Genet. 89 (1992) 105-106
180. 5 reductase gene from patients with recessive congenital methemoglobinemia type II. Blood 85 (1995) 2254-2262
181. Mukai T., Yatsuki H., Arai Y., Joh K., Matsuhashi S., and Hori K. Human aldolase B gene: Characterization of the genomic aldolase B gene and analysis of sequences required for multiple polyadenylations. J. Biochem. 102 (1987) 1043-1051
182. Murakami H., Marelich G.P., Grubb J.H., Kyle J.W., and Sly W.S. Cloning, expression, and sequence homologies of cDNA for human carbonic anhydrase II. Genomics 1 (1987) 159-166
183. Nakajima H., Noguchi T., Yamasaki T., Kono N., Tanaka T., and Tarui S. Cloning of human muscle phosphofructokinase cDNA. FEBS Lett. 223 (1987) 113-116
184. Nakajima H., Kono N., Yamasaki T., Hotta K., Kawachi M., Kuwajima M., Noguchi T., Tanaka T., and Tarui S. Genetic defect in muscle phosphofructokinase deficiency: Abnormal splicing of the muscle phosphofructokinase gene due to a point mutation at the 5′-splice site. J. Biol. Chem. 265 (1990) 9392-9395
185. Naylor C.E., Rowland P., Basak A.K., Gover S., Mason P.J., Bautista J.M., Vulliamy T.J., Luzzatto L., and Adams M.J. Glucose 6-phosphate dehydrogenase mutations causing enzyme deficiency in a model of the tertiary structure of the human enzyme. Blood 87 (1996) 2974-2982
186. Necheles T.F., Steinberg M.H., and Cameron D. Erythrocyte glutathione-peroxidase deficiency. Br. J. Haematol. 19 (1970) 605-612
187. Neubauer B., Lakomek M., Winkler H., Parke M., Hofferbert S., and Schröter W. Point mutations in the L-type pyruvate kinase gene of two children with hemolytic anemia caused by pyruvate kinase deficiency. Blood 77 (1991) 1871-1875
188. Neubauer B.A., Pekrun A., Eber S.W., Lakomek M., and Schröter W. Relation between genetic defect, altered protein structure, and enzyme function in triose-phosphate isomerase (TPI) deficiency. Eur. J. Pediatr. 151 (1992) 232a
189. 844C: A study on its expression in blood cells and muscle. Enzyme 45 (1991) 180-187
190. Nishi S., Seino S., and Bell G.I. Human hexokinase: Sequences of amino- and carboxyl-terminal halves are homologous. Biochem. Biophys. Res. Commun. 157 (1988) 939-943
191. Nishi S., Stoffel M., Xiang K., Shows T.B., Bell G.I., and Takeda J. Human pancreatic beta-cell glucokinase: cDNA sequence and localization of the polymorphic gene to chromosome 7, band p 13. Diabetologia 35 (1992) 743-747
192. 2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J. Biol. Chem. 261 (1986) 13807-13812
193. Noguchi T., Yamada K., Inoue H., Matsuda T., and Tanaka T. The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters. J. Biol. Chem. 262 (1987) 14366-14371
194. O'Brien S.J., Womack J.E., Lyons L.A., Moore K.J., Jenkins N.A., and Copeland N.G. Anchored reference loci for comparative genome mapping in mammals. Nature Genet. 3 (1993) 103-112
195. Ogasawara N., Goto H., Yamada Y., Nishigaki I., Itoh T., Hasegawa I., and Park K.S. Deficiency of AMP deaminase in erythrocytes. Hum. Genet. 75 (1987) 15-18
196. Ogata M. Acatalasemia. Hum. Genet. 86 (1991) 331-340
197. Ookawara T., Davé V., Willems P., Martin J.-J., de Barsy T., Matthys E., and Yoshida A. Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant. Arch. Biochem. Biophys. 327 (1996) 35-40
198. Oort M., Loos J.A., and Prins H.K. Hereditary absence of reduced glutathione in the erythrocyte, a new clinical and biochemical entity?. Vox. Sang. 6 (1961) 370-373
199. Orkin S.H., Daddona P.E., Shewach D.S., Markham A.F., Bruns G.A., Goff S.C., and Kelley W.N. Molecular cloning of human adenosine deaminase gene sequences. J. Biol. Chem. 258 (1983) 12753-12756
200. Paglia D.E., Valentine W.N., and Fink K. Lead poisoning. J. Clin. Invest. 60 (1977) 1362-1366
201. Paglia D.E., Valentine W.N., Brockway R.A., and Nakatani M. Substrate specificity and pH sensitivity of deoxyribonucleotidase and pyrimidine nucleotidase activities in human hemolysates. Exp. Hematol. 15 (1987) 1041-1047
202. Pandolfi P.P., Sonati F., Rivi R., Mason P., Grosveld F., and Luzzatto L. Target disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14 (1995) 5209-5215
203. Pastore, L., et al., Unpublished, 1996
204. Patel P.I., Caskey C.T., and Chinault C.A. Fine structure of the human hypoxanthine guanine phosphoribosyltransferase gene. Mol. Cell. Biol. 6 (1986) 393-403
205. Pekrun A., Neubauer B.A., Eber S.W., Lakomek M., Seidel H., and Schröter W. Triosephosphate isomerase deficiency: Biochemical and molecular genetic analysis for prenatal diagnosis. Clin. Genet. 47 (1995) 175-179
206. Pérignon J.-L., Hamet M., Buc H.A., Cartier P.H., and Derycke M. Biochemical study of a case of hemolytic anemia with increased (85-fold) red cell adenosine deaminase. Clin. Chim. Acta 124 (1982) 205-212
207. Perng L.-I., Chiou S.-S., Liu T.-C., and Chang J.-G. A novel C to T substitution at nucleotide 1360 of cDNA which abolishes a natural Hha I site accounts for a new G6PD deficiency gene in Chinese. Hum. Mol. Genet. 1 (1992) 205
208. Perona G., Guidi G.C., Piga A., Cellerino R., Milani G., Colautti P., Moschini G., and Stievano B.M. Neonatal erythrocyte glutathione peroxidase deficiency as a consequence of selenium imbalance during pregnancy. Br. J. Haematol. 42 (1979) 567-574
209. Perry B.A., and Mohrenweiser H.W. Human triosephosphate iomerase: Substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester. Hum. Genet. 88 (1992) 634-638
210. Persico M.G., Viglietto G., Martini G., Toniolo D., Paonessa G., Moscatelli C., Dono R., Vulliamy T., Luzzatto L., and D'Urso M. Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: Primary structure of the protein and unusual 5′ non-coding region. Nucleic Acids Res. 14 (1986) 2511-2522 7822
211. Pilkis S.J., Weber I.T., Harrison R.W., and Bell G.I. Glucokinase: Structural analysis of a protein involved in susceptibility to diabetes. J. Biol. Chem. 269 (1994) 21925-21928
212. Poggi V., Town M., Foulkes N.S., and Luzzatto L. Identification of a single base change in a new human mutant glucose-6-phosphate dehydrogenase gene by polymerase-chain-reaction amplification of the entire coding region from genomic DNA. Biochem. J. 271 (1990) 157-160
213. Printz R.L., Ardehali H., Koch S., and Granner D.K. Human hexokinase II mRNA and gene structure. Diabetes 44 (1995) 290-294
214. Raben N., Sherman J., Miller F., Mena H., and Plotz P. A 5′ splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease). J. Biol. Chem. 268 (1993) 4963-4967
215. Raben N., Exelbert R., Spiegel R., Sherman J.B., Nakajima H., Plotz P., and Heinisch J. Functional expression of human mutant phosphofructokinase in yeast: Genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency. Am. J. Hum. Genet. 56 (1995) 131-141
216. Raben N., and Sherman J.B. Mutations in muscle phosphofructokinase gene. Hum. Mutat. 6 (1995) 1-6
217. Rosa R., Prehu M.-O., Beuzard Y., and Rosa J. The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocyte. J. Clin. Invest. 62 (1978) 907-915
218. Roth D.E., Venta P.J., Tashian R.E., and Sly W.S. Molecular basis of human carbonic anhydrase II deficiency. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 1804-1808
219. Rottmann W.H., Tolan D.R., and Penhoet E.E. Complete amino acid sequence for human aldolase B derived from cDNA and genomic clones. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 2738-2742
220. Rouger H., Girodon E., Goossens M., Galacteros M., and Cohensolal M. PK Mondor: Prenatal diagnosis of a frameshift mutation in the LR pyruvate kinase gene associated with severe hereditary non-spherocytic haemolytic anaemia. Prenatal Diag. 16 (1996) 97-104
221. Rouger H., Valentin C., Craescu C.T., Galactéros F., and Cohen-Solal M. Five unknown mutations in the LR pyruvate kinase gene associated with severe hereditary nonspherocytic haemolytic anaemia in France. Br. J. Haematol. 92 (1996) 825-830
222. Rowland P., Basak A.K., Gover S., Levy H.R., and Adams M.J. The 3-dimensional structure of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides refined at 2.0-angstrom resolution. Structure 2 (1994) 1073-1087
223. Sakai I., Sharief F.S., Pan Y.-C.E., and Li S.S.-L. The cDNA and protein sequences of human lactate dehydrogenase B. Biochem. J. 248 (1987) 933-936
224. Sakakibara M., Mukai T., and Hori K. Nucleotide sequence of a cDNA clone for human aldolase: A messenger RNA in the liver. Biochem. Biophys. Res. Commun. 131 (1985) 413-420
225. Sakakibara M., Mukai T., Yatsuki H., and Hori K. Human aldolase isozyme gene: The structure of multispecies aldolase B mRNAs. Nucleic Acids Res. 13 (1985) 5055-5069
226. Sakoda S., Shanske S., DiMauro S., and Schon E.A. Isolation of a cDNA encoding the B isozyme of human phosphoglycerate mutase (PGAM) and characterization of the PGAM gene family. J. Biol. Chem. 263 (1988) 16899-16905
227. Santisteban I., Arredondo-Vega F.X., Kelly S., Debre M., Fischer A., Pérignon J.L., Hilman B., Eldahr J., Dreyfus D.H., Howell P.L., and Hershfield M.S. Four new adenosine deaminase mutations, altering a zinc-binding histidine, two conserved alanine, and a 5′ splice site. Hum. Mutat. 5 (1995) 243-250
228. Santisteban I., Arredondo-Vega F.X., Kelly S., Loubser M., Meydan N., Roifman C., Howell P.L., Bowen T., Weinberg K.I., Schroeder M.L., and Hershfield M.S. Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: Implications for evolution of a CpG hotspot and expression of a transduced ADAcDNA. Hum. Mol. Genet. 4 (1995) 2081-2087
229. Satoh H., Tani K., Yoshida M.C., Sasaki M., Miwa S., and Fujii H. The human liver-type pyruvate kinase (PKL) gene is on chromosome 1 at band q21. Cytogenet. Cell. Genet. 47 (1988) 132-133
230. Schirmer R.H., Müller J.G., and Krauth-Siegel R.L. Disulfide-reductase inhibitors as chemotherapeutic agents: The design of drugs for trypanosomiasis and malaria. Angew, Chem., Int. Ed. Engl. 34 (1995) 141-154
231. Schneider A., Westwood B., Yim C., Prchal J., Berkow R., Labotka R., Warrier R., and Beutler E. Triosephosphate isomerase deficiency: Occurrence of point mutation in amino acid 104 in multiple apparently unrelated families. Am. J. Hematol. 50 (1995) 263-268
232. Schneider A.S., Valentine W.N., Hattori M., and Heins H.L. Hereditary hemolytic anemia with triosephosphate isomerase deficiency. New Engl. J. Med. 272 (1965) 229-235
233. Sculley D.G., Dawson P.A., Emmerson B.T., and Gordon R.B. A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Hum. Genet. 90 (1992) 195-207
234. Shanske S., Sakoda S., Hermodson M.A., DiMauro S., and Schon E.A. Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase. J. Biol. Chem. 262 (1987) 14612-14617
235. Sherman J.B., Raben N., Nicastri C., Argov Z., Nakajima H., Adams E.M., Eng C.M., Cowan T.M., and Plotz P.H. Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII-and their population frequency. Am J. Hum. Genet. 55 (1994) 305-313
236. Shi Z.-Z., Habib G.M., Rhead W.J., Gahl W.A., He X., Sazer W.A., and Lieberman M.W. Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nature Genet. 14 (1996) 361-365
237. Shinohara K., and Tanaka K.R. Hereditary deficiency of erythrocyte acetylcholinesterase. Am. J. Hematol. 7 (1979) 313-321
238. Sierra-Rivera E., Dasouki M., Summer M.L., Krishnamani M.R.S., Meredith M., Rao P.N., Phillips J.A., and Freeman M.L. Assignment of the human gene (GLCLR) that encodes the regulatory subunit of γ-glutamylcysteine synthetase to chromosome lp21. Cytogenet. Cell. Genet. 72 (1996) 252-254
239. Sierra-Rivera E., Summer M.L., Dasouki M., Krishnamani M.R.S., Phillips J.A., and Freeman M.L. Assignment of the human gene (GLCLR) that encodes the heavy subunit of γ-glutamylcysteine synthetase to chromosome 6. Cytogenet. Cell. Genet. 70 (1995) 278-279
240. Smith B.F., Stedman H., Rajpurohit Y., Henthorn P.S., Wolfe J.H., Patterson D.F., and Giger U. Molecular basis of canine muscle type phosphofructokinase deficiency. J. Biol. Chem. 271 (1996) 20070-20074
241. Stambolian D., Ai Y., Sidjanin D., Nesburn K., Sathe G., Rosenberg M., and Bergsma D.J. Cloning of the galactokinase cDNA and identification of mutations in two families with cataracts. Nature Genet. 10 (1995) 307-312
242. Stevens D.J., Wanachiwanawin W., Mason P.J., Vulliamy T.J., and Luzzatto L. G6PD Canton a common deficient variant in South East Asia caused by a 459 Arg → Leu mutation. Nucleic Acids Res. 18 (1990) 7190
243. Sukenaga Y., Ishida K., Takeda T., and Takagi K. cDNA sequence coding for human glutathione peroxidase. Nucleic Acids Res. 15 (1987) 7178
244. Sundaram V., Rumbolo P., Grubb J., Strisciuglio P., and Sly W.S. Carbonic anhydrase II deficiency: Diagnosis and carrier detection using differential enzyme inhibition and inactivation. Am. J. Hum. Genet. 38 (1986) 125-136
245. Szeinberg A., Kahana D., Slava G., Zaidman J., and Ben-Ezzer B. Hereditary deficiency of adenylate kinase in red blood cells. Acta Haematol. 42 (1969) 111-126
246. Takahara S., and Miyamoto H. Clinical and experimental studies on the odontogenous progressive necrotic ostitis due to lack of blood catalase. J. Otorhinol. Soc. Jpn. 51 (1948) 163-164 (in Japanese)
247. Takano T., and Li S.S.-L. Human testicular lactate dehydrogenase-C gene is interrupted by six introns at positions homologous to those of LDH-A(muscle) and LDH-B(heart) genes. Biochem. Biophys. Res. Commun. 159 (1989) 579-583
248. Takano T., and Li S.S.-L. Structure of human lactate dehydrogenase-B gene. Biochem. J. 257 (1989) 921-924
249. Takenaka M., Noguchi T., Inoue H., Yamada K., Matsuda T., and Tanaka T. Rat pyruvate kinase M gene. Its complete structure and characterization of the 5′-flanking region. J. Biol. Chem. 264 (1989) 2363-2367
250. Takenaka M., Noguchi T., Sadahiro S., Hirai H., Yamada K., Matsuda T., Imai E., and Tanaka T. Isolation and characterization of the human pyruvate kinase M gene. Eur. J. Biochem. 198 (1991) 101-106
251. Takizawa T., Huang I.-Y., Ikuta T., and Yoshida A. Human glucose-6-phosphate dehydrogenase: Primary structure and cDNA cloning. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4157-4161
252. Takizawa T., Yoneyama Y., Miwa S., and Yoshida A. A single nucleotide base transition is the basis of the common human glucose-6-phosphate dehydrogenase variant A(+). Genomics 1 (1987) 228-231
253. Tang T.K., Huang C.-S., Huang M.-J., Tam K.-B., Yeh C.H., and Tang C.J. Diverse point mutations result in glucose-6-phosphate dehydrogenase (G6PD) polymorphism in Taiwan. Blood 79 (1992) 2135-2140
254. Tang T.K., Chen H.-L., Huang C.-S., and Liu T.-H. Identification of a novel G6PD mutation (G6PD NanKang) and the association of F8C/G6PD haplotypes in Chinese. Blood 86 Suppl. 1 (1995) 134a
255. Tani K., Fujii H., Nagata S., and Miwa S. Human liver type pyruvate kinase: Complete amino acid sequence and the expression in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 1792-1795
256. 2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatoma. Gene 73 (1988) 509-516
257. Tanoue A., Endo F., and Matsuda I. Structural organization of the gene for human prolidase (peptidase D) and demonstration of a partial gene deletion in a patient with prolidase deficiency. J. Biol. Chem. 265 (1990) 11306-11311
258. Tanoue A., Endo F., Akaboshi I., Oono T., Arata J., and Matsuda I. Molecular defect in siblings with prolidase deficiency and absence or presence of clinical symptoms. A0.8-kb deletion with breakpoints at the short, direct repeat in the PEPD gene and synthesis of abnormal messenger RNA and inactive polypeptide. J. Clin. Invest. 87 (1991) 1171-1176
259. Tarui S., Okuno G., Ikuno Y., Tanaka T., Suda M., and Nishikawa M. Phosphofructokinase deficiency in skelctal muscle. A new type of glycogenesis. Biochem. Biophys. Res. Commun. 19 (1965) 517-523
260. Tolan D.R., Niclas J., Bruce B.D., and Lebo R.V. Evolutionary implications of the human aldolase-A, -B, -C, and -pseudogene chromosome locations. Am. J. Hum. Genet. 41 (1987) 907-924
261. Tolan D.R. Molecular basis of hereditary fructose intolerance: Mutations and polymorphisms in the human aldolase B gene. Hum. Mutat. 6 (1995) 210-218
262. 5 reductase gene. Gene 80 (1989) 353-361
263. Toren A., Brok-Simoni F., Ben-Bassat I., Holtman F., Mandel M., Neumann Y., Ramot B., Rechavi G., and Kende G. Congenital haemolytic anaemia associated with adenylate kinase deficiency. Br. J. Haematol. 87 (1994) 376-380
264. Torrance J.D., Whittaker D., and Beutler E. Purification and properties of human erythrocyte pyrimidine 5′-nucleotidase. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 3701-3704
265. Toscano A., Tsujino S., Vita G., Shanske S., Messina C., and DiMauro S. Molecular basis of muscle phosphoglycerate mutase (PGAM-M) deficiency in the Italian kindred. Muscle Nerve 19 (1996) 1134-1137
266. Tougard P., Le T.H., Minard P., Desmadril M., Yon J.M., Bizebard T., Lebras G., and Dumas C. Structural and functional properties of mutant Arg203Pro from yeast phosphoglycerate kinase, as a model of phosphoglycerate kinase-Uppsala. Protein Eng. 9 (1996) 181-187
267. Tsujibo H., Tiano H.F., and Li S.S.-L. Nucleotide sequences of the cDNA and an intronless pseudogene for human lactate dehydrogenase-A isozyme. Eur. J. Biochem. 147 (1985) 9-15
268. Tsujino S., Servidei S., Tonin P., Shanske S., Azan G., and DiMauro S. Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am. J. Hum. Genet. 54 (1994) 812-819
269. Tsujino S., Tonin P., Shanske S., Nohria V., Boustany R.-M., Lewis D., Chen Y.-T., and DiMauro S. A splice junction mutation in a new myopathic variant of phosphoglycerate kinase deficiency (PGK North Carolina). Ann. Neurol. 35 (1994) 349-353
270. Tsujino S., Shanske S., and DiMauro S. Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency. Muscle Nerve Suppl. 3 (1995) S45-S49
271. Turner G., Fletcher J., Elber J., Yanagawa Y., Davé V., and Yoshida A. Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred. Br. J. Haematol. 91 (1995) 60-65
272. Uenaka R., Nakajima H., Noguchi T., Imamura K., Hamagauchi T., Tomita K., Yamada K., Kuwajima M., Kono N., Tanaka T., and Matsuzawa Y. Compound heterozygous mutations affecting both hepatic and erythrocyte isozymes of pyruvate kinase. Biochem. Biophys. Res. Commun. 208 (1995) 991-998
273. Valentine W.N., Tanaka K.R., and Miwa S. A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia. Trans. Assoc. Am. Physicians 74 (1961) 100-110
274. Valentine W.N., Oski F.A., Paglia D.E., Baughan M.A., Schneider A.S., and Naiman J.L. Hereditary hemolytic anemia with hexokinase deficiency. Role of hexokinase in erythrocyte aging. New Engl. J. Med. 276 (1967) 1-11
275. Valentine W.N., Hsieh H., Paglia D.E., Anderson H.M., Baughan M.A., Jaffé E.R., and Garson O.M. Hereditary hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. New Engl. J. Med. 280 (1969) 528-534
276. Valentine W.N., Fink K., Paglia D.E., Harris S.R., and Adams W.S. Hereditary hemolytic anemia with human erythrocyte pyrimidine 5′-nucleotidase deficiency. J. Clin. Invest. 54 (1974) 866-879
277. Valentine W.N., Paglia D.E., Tartaglia A.P., and Gilsanz F. Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate. Science 195 (1977) 783-785
278. Valerio D., Duyvesteyn M.G.C., Kahn P.M., van Kessel A.G., de Waard A., and van der Eb A.J. Isolation of cDNA clones for human adenosine deaminase. Gene 25 (1983) 231-240
279. Van Acker K.J., Simmonds H.A., and Cameron P.C. Complete deficiency of adenine phosphoribosyltransferase: Report of a family. New Engl. J. Med. 297 (1977) 127-132
280. Vasconcelos O., Sivakumar K., Dalakas M.C., Quezado M., Nagle J., Leon-Monzon M., Dubnick M., Gajdusek C., and Goldfarb L.G. Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenzai Jewish patients with Tarui disease. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10322-10326
281. Venta P.J., Welty R.J., Johnson T.M., Sly W.S., and Tashan R.E. Carbonic anhydrase II deficiency syndrome in a Belgian family is caused by a point mutation at an invariant histidine residue (107 His→Tyr): Complete structure of the normal human CAII gene. Am. J. Hum. Genet. 49 (1991) 1082-1090
282. Viglietto G., Montanaro V., Calabro V., Vallone D., D'Urso M., Persico M.G., and Battis-tuzzi G. Common glucose-6-phosphate dehydrogenase (G6PD) variants from the Italian population: Biochemical and molecular characterization. Ann. Hum. Genet. 54 (1990) 1-15
283. Vives-Corrons J.-L., Kuhl W., Pujades M.A., and Beutler E. Molecular genetics of G6PD Mediterranean variant and description of a new mutant, G6PD Andalus 1361A. Am. J. Hum. Genet. 47 (1990) 575-579
284. Vives Corrons J.L.I., Rovira A., Pujades A., Vulliamy T., and Luzzatto L. Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) in Spain and identification of two new base substitutions in the G6PD gene. Blood 84 Suppl. 1 (1994) 551a
285. Vora S., and Francke U. Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 3738-3742
286. Vulliamy T.J., D'Urso M., Battistuzzi G., Estrada M., Foulkes N.S., Martini G., Calabro V., Poggi V., Giordano R., Town M., Luzzatto L., and Persico M.G. Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5171-5175
287. Vulliamy T.J., Wanachiwanawin W., Mason P.J., and Luzzatto L. G6PD Mahidol, a common deficient variant in South East Asia is caused by a (163) glycine → serine mutation. Nucleic Acids Res. 17 (1989) 5868
288. Vulliamy T., Beutler E., and Luzzatto L. Variants of glucose-6-phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene. Hum. Mutat. 2 (1993) 159-167
289. Walker J.I.H., Layton D.M., and Bellingham A.J. DNA sequence abnormalities in human glucose 6-phosphate isomerase deficiency. Hum. Mol. Genet. 2 (1993) 327-329
290. Walker J.I.H., Morgan M.J., and Faik P. Structure and organization of the human glucose phosphate isomerase gene (GPl). Genomics 29 (1995) 261-265
291. Watanabe M., Zingg B.C., and Mohrenweiser H.W. Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus. Am. J. Hum. Genet. 58 (1996) 308-316
292. Weimer T.A., Salzano F.M., Westwood B., and Beutler E. Molecular characterization of glucoses-6-phosphate dehydrogenase (G6PD) variants from Brazil. Hum. Biol. 65 (1993) 41
293. Wen J.-K., Osumi T., Hashimoto T., and Ogata M. Molecular analysis of human acatalasemia. Identification of a splicing mutation. J. Mol. Biol. 211 (1990) 383-393
294. Wiginton D.A., Kaplan D.J., States J.C., Akeson A.L., Perme C.M., Bilyk I.J., Vaughn A.J., Lattier D.L., and Hutton J.J. Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry 25 (1986) 8234-8244
295. Willard H.F., Goss S.J., Holmes M.T., and Munrose D.L. Regional localization of the phos-phoglycerate kinase gene and pseudogene on the human X chromosome and assignment of a related DNA sequence on chromosome 19. Hum. Genet. 71 (1985) 138-143
296. Wilson D.E., Swallow D.M., and Povey S. Assignment of the human gene for uridine 5′-monophosphate phosphohydrolase (UMPH2) to the long arm of chromosome 17. Ann. Hum. Genet. 50 (1986) 223-227
297. Xu W.M., and Beutler E. The characterization of gene mutations for human glucose phosphate isomerase (GPI) deficiency associated with chronic hemolytic anemia. J. Clin. Invest. 94 (1994) 2326-2329
298. Xu W., Lee P., and Beutler E. Human glucose phosphate isomerase: Exon mapping and gene structure. Genomics 29 (1995) 732-739
299. Xu W., Westwood B., Bartsocas C.S., Malcorra-Azpiazu J.J., Indrak K., and Beutler E. Glucose-6-phosphate dehydrogenase mutations and haplotypes in various ethnic groups. Blood 85 (1995) 257-263
300. Yoshida A. Glucose 6-phosphate dehydrogenase of human erythrocytes. I. Purification and characterization of normal (B+) enzyme. J. Biol. Chem. 241 (1966) 4966-4976
301. Yoshida A., Watanabe S., Chen S.-H., Giblett E.R., and Malcolm L.A. Human phospho-glycerate kinase. II. Structure of a variant enzyme. J. Biol. Chem. 247 (1972) 446-449
302. Yoshida A., Twele T.W., Davé V., and Beutler E. Molecular abnormality of a phosphoglycerate kinase variant (PGK-Alabama). Blood Cells Mol. Dis. 21 (1995) 179-181
303. 5 reductase. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3609-3613